A new test can detect the biological signature of Parkinson’s disease before symptoms arise. Stanford Medicine neurologist, Kathleen Poston, MD, MS, explains why early diagnosis opens the door to better therapies.
Read the full story: [ Ссылка ]
Kathleen Poston, MD, MS, is a Professor of Neurology & Neurological Sciences and (by courtesy) Neurosurgery at Stanford University Medical Center. Her research focuses on develop imaging and biological biomarkers to advance our understanding of the pathophysiology underlying the cognitive, behavioral, and motor symptoms characteristic of Parkinson’s disease and related movement disorders.
Lisa Kim is Senior Manager of Media Relations for Stanford Medicine and Stanford Health Care. Lisa has a deep background in journalism, as she is an Emmy Award-winning journalist who has covered stories on both the national and local levels.
#ParkinsonsResearch #ClinicalTrials #GameChanger #BiomarkerBreakthrough #MedicalInnovation #TreatmentAdvancement #NeurologyDiscovery #HealthcareProgress #parkinson #breakthrough #patientcare
.
.
.
Stanford Medicine advances human health through world-class biomedical research, education and patient care. Bringing together the resources of Stanford University School of Medicine, Stanford Health Care and Lucile Packard Children's Hospital, Stanford Medicine is committed to training future leaders in biomedicine and translating the latest discoveries into new ways to prevent, diagnose and treat disease.
The Stanford Medicine YouTube channel is a curated collection of contributions from our School of Medicine departments, divisions, students, and the community. Our diverse content includes coverage of events, presentations, lectures, and associated stories about the people of Stanford Medicine.
